LAV Asset Management (Hong Kong) Limited - Net Worth and Insider Trading
LAV Asset Management (Hong Kong) Limited Net Worth
The estimated net worth of LAV Asset Management (Hong Kong) Limited is at least $2.8 Billion dollars as of 2024-06-22. LAV Asset Management (Hong Kong) Limited is the 2102 Investment manager of Innovent Biologics Inc and owns about 77,036,540 shares of Innovent Biologics Inc (HKSE:01801) stock worth over $2.8 Billion. Details can be seen in LAV Asset Management (Hong Kong) Limited's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that LAV Asset Management (Hong Kong) Limited has not made any transactions after 2023-03-08 and currently still holds the listed stock(s).
Transaction Summary of LAV Asset Management (Hong Kong) Limited
LAV Asset Management (Hong Kong) Limited Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, LAV Asset Management (Hong Kong) Limited owns 1 companies in total, including Innovent Biologics Inc (HKSE:01801) .
Insider Ownership Summary of LAV Asset Management (Hong Kong) Limited
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:01801 | Innovent Biologics Inc | 2023-03-08 | 2102 Investment manager |
LAV Asset Management (Hong Kong) Limited Latest Holdings Summary
LAV Asset Management (Hong Kong) Limited currently owns a total of 1 stock. LAV Asset Management (Hong Kong) Limited owns 77,036,540 shares of Innovent Biologics Inc (HKSE:01801) as of March 8, 2023, with a value of $2.8 Billion.
Latest Holdings of LAV Asset Management (Hong Kong) Limited
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:01801 | Innovent Biologics Inc | 2023-03-08 | 77,036,540 | 36.80 | 2,834,944,672 |
Holding Weightings of LAV Asset Management (Hong Kong) Limited
LAV Asset Management (Hong Kong) Limited Form 4 Trading Tracker
According to the SEC Form 4 filings, LAV Asset Management (Hong Kong) Limited has made a total of 1 transactions in Innovent Biologics Inc (HKSE:01801) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Innovent Biologics Inc is the acquisition of 350,000 shares on March 8, 2023, which cost LAV Asset Management (Hong Kong) Limited around $14 Million.
Insider Trading History of LAV Asset Management (Hong Kong) Limited
- 1
LAV Asset Management (Hong Kong) Limited Trading Performance
GuruFocus tracks the stock performance after each of LAV Asset Management (Hong Kong) Limited's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by LAV Asset Management (Hong Kong) Limited is -8.52%. GuruFocus also compares LAV Asset Management (Hong Kong) Limited's trading performance to market benchmark return within the same time period. The performance of stocks bought by LAV Asset Management (Hong Kong) Limited within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how LAV Asset Management (Hong Kong) Limited's insider trading performs compared to the benchmark.
Performance of LAV Asset Management (Hong Kong) Limited
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -3.88 | | | | | |
| Relative Return to S&P 500(%) | -6.71 | | | | | |
LAV Asset Management (Hong Kong) Limited Ownership Network
LAV Asset Management (Hong Kong) Limited Owned Company Details
What does Innovent Biologics Inc do?
Who are the key executives at Innovent Biologics Inc?
LAV Asset Management (Hong Kong) Limited is the 2102 Investment manager of Innovent Biologics Inc. Other key executives at Innovent Biologics Inc include 2502 Approved lending agent JPMorgan Chase & Co. , 2101 Beneficial owner Yu De-chao Michael , and Temasek Holdings (private) Limited .
Innovent Biologics Inc (HKSE:01801) Insider Trades Summary
Over the past 18 months, LAV Asset Management (Hong Kong) Limited made 1 insider transaction in Innovent Biologics Inc (HKSE:01801) with a net purchase of 350,000. Other recent insider transactions involving Innovent Biologics Inc (HKSE:01801) include a net sale of 0 shares made by Morgan Stanley , a net purchase of 357,276 shares made by The Capital Group Companies, Inc. , and a net sale of 1,409,211 shares made by Yu De-chao Michael .
In summary, during the past 3 months, insiders sold 906,250 shares of Innovent Biologics Inc (HKSE:01801) in total and bought 0 shares, with a net sale of 906,250 shares. During the past 18 months, 10,350,711 shares of Innovent Biologics Inc (HKSE:01801) were sold and 9,565,276 shares were bought by its insiders, resulting in a net sale of 785,435 shares.
Innovent Biologics Inc (HKSE:01801)'s detailed insider trading history can be found in Insider Trading Tracker table.
Innovent Biologics Inc Insider Transactions
LAV Asset Management (Hong Kong) Limited Mailing Address
Above is the net worth, insider trading, and ownership report for LAV Asset Management (Hong Kong) Limited. Currently GuruFocus does not have mailing address information for LAV Asset Management (Hong Kong) Limited.
Discussions on LAV Asset Management (Hong Kong) Limited
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
